# Nervio

> Nervio is an Israeli-American digital health company building AIM, an AI-powered intraoperative neuromonitoring (IONM) system that turns raw surgical signal data into real-time alerts and recommendations. Founded in 2020 by brothers Dr. Omer Zarchi and Nir Zarchi, the company aims to prevent avoidable paralysis and nerve injury during spine and neurosurgery at a time when the number of surgeries is climbing and the pool of expert neurophysiologists is shrinking. Nervio operates from Nashville, Tennessee with an R&D center in Israel, and its technology has been developed with input from dozens of neurophysiologists across more than 1,000 surgical cases.

- **Founded:** 2020
- **Headquarters:** Nashville, Tennessee, USA (R&D in Israel)
- **Founders:** Dr. Omer Zarchi (Co-Founder & Chief Scientific Officer), Nir Zarchi (Co-Founder & Chief Product / Innovation Officer)
- **Team size:** ~20 employees
- **Products:** AIM
- **Notable:** Developed AIM, described as the first AI-powered IONM decision-support system, validated across 1,000+ surgical cases., Raised a $2.5M seed round led by eHealth Ventures (announced early 2024)., Launched its first US clinical trial with Global Neurosciences Institute (2022).

## Products & services

- **AIM** — An AI-powered intraoperative neurophysiological monitoring (IONM) system that converts raw surgical signal data into real-time alerts and recommendations. Built on machine-learning algorithms and validated across more than 1,000 surgical cases, AIM works as an adjunct that helps neurophysiologists and surgical teams detect neurologic risk earlier and monitor more cases at once.

## Achievements

- Developed AIM, described as the first AI-powered IONM decision-support system, validated across 1,000+ surgical cases.
- Raised a $2.5M seed round led by eHealth Ventures (announced early 2024).
- Launched its first US clinical trial with Global Neurosciences Institute (2022).
- Recruited a leadership bench including past ASNM presidents Dr. Richard Vogel and clinical experts, plus a former FDA official on regulatory affairs.
- Secured a grant from the Israel Innovation Authority to support R&D and regulatory work.

## Latest updates

- **2024-12** — Dr. Richard Vogel, past president of the American Society of Neurophysiological Monitoring, named US CEO.
- **2024-01** — Closed a $2.5M seed round led by eHealth Ventures.
- **2025** — Advancing validation and commercial partnerships and pursuing a post-seed / Round A raise; presenting research at IONM conferences including ASNM and ASET.

## Links

- Website: https://www.nervio.ai/
- LinkedIn: https://www.linkedin.com/company/nervio-ai/

---

Profile page: https://yespress.io/nervio
Published by YesPress — https://yespress.io
Last updated: 2026-07-03